CS276439B6 - Pharmaceutical for treating auto-immune diseases - Google Patents
Pharmaceutical for treating auto-immune diseases Download PDFInfo
- Publication number
- CS276439B6 CS276439B6 CS902689A CS268990A CS276439B6 CS 276439 B6 CS276439 B6 CS 276439B6 CS 902689 A CS902689 A CS 902689A CS 268990 A CS268990 A CS 268990A CS 276439 B6 CS276439 B6 CS 276439B6
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- animals
- cells
- group
- proteoglycan
- carbon atoms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3918082A DE3918082A1 (de) | 1989-06-02 | 1989-06-02 | Mittel gegen autoimmunerkrankungen |
Publications (2)
Publication Number | Publication Date |
---|---|
CS268990A3 CS268990A3 (en) | 1992-01-15 |
CS276439B6 true CS276439B6 (en) | 1992-05-13 |
Family
ID=6381972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS902689A CS276439B6 (en) | 1989-06-02 | 1990-05-31 | Pharmaceutical for treating auto-immune diseases |
Country Status (14)
Country | Link |
---|---|
US (1) | US5266564A (fr) |
EP (1) | EP0474712B1 (fr) |
JP (1) | JP2977894B2 (fr) |
AT (1) | ATE94757T1 (fr) |
AU (1) | AU5670690A (fr) |
CA (1) | CA2056421C (fr) |
CS (1) | CS276439B6 (fr) |
DE (2) | DE3918082A1 (fr) |
DK (1) | DK0474712T3 (fr) |
ES (1) | ES2060173T3 (fr) |
GR (1) | GR1001195B (fr) |
IE (1) | IE64039B1 (fr) |
WO (1) | WO1990014829A1 (fr) |
ZA (1) | ZA904196B (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3941009A1 (de) * | 1989-12-12 | 1991-06-13 | Medmark Pharma Gmbh | Eliminierung von aktivierten lymphozyten |
SI9720020B (en) * | 1996-02-09 | 2001-12-31 | Basf Ag | Human antibodies that bind human TNF alpha |
WO2000037088A1 (fr) * | 1998-12-21 | 2000-06-29 | Inkeysa.Sa | Utilisation d'etherlysophospholipides en tant qu'agents anti-inflammatoires |
SE9902155L (sv) * | 1999-06-09 | 2000-12-10 | Bjoern Rydevik | Serum antibodies |
JP2002228764A (ja) * | 2001-02-02 | 2002-08-14 | Fuji Photo Film Co Ltd | 透光性シート体検出装置 |
WO2008055996A1 (fr) * | 2006-11-10 | 2008-05-15 | Alphaptose Gmbh | Forme galénique destinée à la voie orale comprenant des composés de glycérol trisubstitués |
EP2089711B1 (fr) | 2006-11-10 | 2012-09-12 | Alphaptose Gmbh | Procédés et compositions permettant de détecter des mimétiques de ligands de récepteurs |
US20100130449A1 (en) * | 2006-11-10 | 2010-05-27 | Alphaptose Gmbh | Use of Tri-Substituted Glycerol Compounds for the Treatment of Radiation Injuries |
US8637688B2 (en) * | 2006-12-20 | 2014-01-28 | Julia Diederichs | Topical dosage form comprising tri-substituted glycerol compounds |
US8697138B2 (en) | 2007-03-28 | 2014-04-15 | Aker Biomarine As | Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders |
CA2682068C (fr) | 2007-03-28 | 2017-11-28 | Aker Biomarine Asa | Compositions d'huile de krill biologiquement efficaces |
CN103815114A (zh) * | 2007-08-29 | 2014-05-28 | 阿克海洋生物股份公司 | 新的制备磷虾粉的方法 |
US20100226977A1 (en) * | 2007-08-29 | 2010-09-09 | Aker Biomarine Asa | Low viscosity phospholipid compositions |
US8372812B2 (en) * | 2009-02-26 | 2013-02-12 | Aker Biomarine Asa | Phospholipid and protein tablets |
WO2013156630A1 (fr) | 2012-04-20 | 2013-10-24 | Alphaptose Gmbh | Enantiomère s d'un composé glycérol tri-substitué |
AU2014203179C1 (en) | 2013-06-14 | 2017-05-04 | Aker Biomarine Antarctic As | Lipid extraction processes |
GB201400431D0 (en) | 2014-01-10 | 2014-02-26 | Aker Biomarine As | Phospholipid compositions and their preparation |
KR102310765B1 (ko) | 2015-02-11 | 2021-10-12 | 에이커 바이오마린 앤탁틱 에이에스 | 지질 조성물 |
KR20170118125A (ko) | 2015-02-11 | 2017-10-24 | 에이커 바이오마린 앤탁틱 에이에스 | 지질 추출 공정 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2009342C3 (de) * | 1970-02-27 | 1980-12-18 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen | Verwendung von Glycerin-alkyläther-(l)-phosphorsäure-(3)-monocholinestern |
DE2009343C3 (de) * | 1970-02-27 | 1980-10-23 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen | Verwendung von Lysolecithinen als immunologische Adjuvantien |
DE2619686C2 (de) * | 1976-05-04 | 1986-08-07 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Verwendung eines Lysolecithins zur Tumorbehandlung |
CH670763A5 (fr) * | 1985-08-02 | 1989-07-14 | Seuref Ag | |
DE3530767A1 (de) * | 1985-08-28 | 1987-03-12 | Max Planck Gesellschaft | Mittel gegen multiple sklerose |
-
1989
- 1989-06-02 DE DE3918082A patent/DE3918082A1/de active Granted
-
1990
- 1990-05-29 GR GR900100406A patent/GR1001195B/el not_active IP Right Cessation
- 1990-05-31 JP JP2507957A patent/JP2977894B2/ja not_active Expired - Fee Related
- 1990-05-31 CS CS902689A patent/CS276439B6/cs not_active IP Right Cessation
- 1990-05-31 DE DE90908504T patent/DE59002863D1/de not_active Expired - Fee Related
- 1990-05-31 EP EP90908504A patent/EP0474712B1/fr not_active Expired - Lifetime
- 1990-05-31 ES ES90908504T patent/ES2060173T3/es not_active Expired - Lifetime
- 1990-05-31 CA CA002056421A patent/CA2056421C/fr not_active Expired - Fee Related
- 1990-05-31 AT AT90908504T patent/ATE94757T1/de not_active IP Right Cessation
- 1990-05-31 US US07/777,248 patent/US5266564A/en not_active Expired - Lifetime
- 1990-05-31 DK DK90908504.5T patent/DK0474712T3/da active
- 1990-05-31 WO PCT/EP1990/000870 patent/WO1990014829A1/fr active IP Right Grant
- 1990-05-31 AU AU56706/90A patent/AU5670690A/en not_active Abandoned
- 1990-06-01 IE IE198790A patent/IE64039B1/en not_active IP Right Cessation
- 1990-06-01 ZA ZA904196A patent/ZA904196B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JP2977894B2 (ja) | 1999-11-15 |
CA2056421C (fr) | 2000-10-10 |
IE64039B1 (en) | 1995-06-28 |
GR1001195B (el) | 1993-06-07 |
CA2056421A1 (fr) | 1990-12-03 |
US5266564A (en) | 1993-11-30 |
CS268990A3 (en) | 1992-01-15 |
GR900100406A (en) | 1991-11-15 |
EP0474712B1 (fr) | 1993-09-22 |
ATE94757T1 (de) | 1993-10-15 |
JPH04507096A (ja) | 1992-12-10 |
DK0474712T3 (da) | 1993-11-29 |
WO1990014829A1 (fr) | 1990-12-13 |
DE3918082C2 (fr) | 1992-02-06 |
AU5670690A (en) | 1991-01-07 |
ES2060173T3 (es) | 1994-11-16 |
DE3918082A1 (de) | 1991-01-24 |
IE901987L (en) | 1990-12-02 |
ZA904196B (en) | 1991-03-27 |
EP0474712A1 (fr) | 1992-03-18 |
DE59002863D1 (de) | 1993-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CS276439B6 (en) | Pharmaceutical for treating auto-immune diseases | |
Macdermott et al. | Alterations of the immune system in ulcerative colitis and Crohn's disease | |
Kita et al. | Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. | |
Skelly et al. | Making sense of the schistosome surface | |
Voorthuis et al. | Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon‐gamma in Lewis rats | |
US5013661A (en) | Lipopolysaccharide-specific acyloxyacyl hydrolase | |
Harvey | Cytolytic toxins | |
Fallon et al. | Immune-dependent chemotherapy of schistosomiasis | |
Winn et al. | Acute destruction by humoral antibody of rat skin grafted to mice: the role of complement and polymorphonuclear leukocytes | |
EP0251134B1 (fr) | Compositions pour prévenir le rejet de la greffe | |
US4778788A (en) | Agent against multiple sclerosis | |
Sher et al. | Schistosomiasis: immunologic properties of developing schistosomula. | |
US7608246B2 (en) | Apolipoprotein E as an adjuvant for lipid antigens | |
AU665764B2 (en) | Methods and compositions for the prevention, diagnosis, and treatment of inflammatory serosal disease and related conditions | |
RAMSEY et al. | Chemotaxis | |
Bräuer et al. | Changes of immunoregulatory properties and induction of autoimmune reactivity to cartilage in rabbits with antigen-induced arthritis | |
Internationalis | Bacteriology, immunology | |
Du Clos | THE SUPPRESSOR CELL IN NEONATALLY INDUCED TOLERANCE. | |
SKOPISKA | Effect of lipopolysaccharide on the development of cell-mediated immunity to transplantation antigens | |
Dion | Septic shock, the second messenger system and the complement system | |
Ginsburg et al. | Bayer-Symposium VI, Experimental Models of Chronic Inflammatory Diseases, 256-299 (1977) by Springer-Verlag 1977 Experimental Models of Streptococcal Arthritis: Pathogenetic Role of Streptococcal Products and | |
Smiley | The immune response in rheumatoid synovitis | |
Weltzin | Intracellular Calcium and Protein Kinase C Regulate Nonspecific Cell-Mediated Cytotoxicity by Mouse Lymphocytes (Calmodulin) | |
Li | Molecular mechanisms controlling NF-κB activation in rheumatoid arthritis | |
Cutler | Serum-mediated interactions between Bacteroides gingivalis and polymorphonuclear leukocytes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
IF00 | In force as of 2000-06-30 in czech republic | ||
MM4A | Patent lapsed due to non-payment of fee |
Effective date: 20080531 |